NCT03309657View on ClinicalTrials.gov

Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

May 1, 2020

Study Completion Date

June 1, 2020

Conditions
Pharmacokinetics
Interventions
DRUG

Ceftolozane/tazobactam

This is an observational pharmacokinetic study whereby patients received a single dose of ceftolozane/tazobactam and plasma and cerebrospinal fluid samples were subsequently collected and analyzed to described the pharmacokinetics.

Trial Locations (1)

4029

Royal Brisbane and Women's Hospital, Brisbane

All Listed Sponsors
collaborator

The University of Queensland

OTHER

lead

Royal Brisbane and Women's Hospital

OTHER_GOV

NCT03309657 - Pharmacokinetics of Ceftolozane/Tazobactam in Plasma and Cerebrospinal Fluid | Biotech Hunter | Biotech Hunter